LITSLite Strategy, Inc.
0.9449USD-6.45%Mkt Cap: 31.79M USDP/E: Last update: 2026-06-01

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed it…

Indicators:|

Key Statistics

Company
Market Cap31.79M USD
Enterprise Value26.82M USD
Revenue (TTM)
Gross Profit-1.97M USD
Net Income (TTM)-15.95M USD
Revenue/Share
Last Price0.9449 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees4
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG2.22
EV/EBITDA-1.57
EV/Revenue
P/S
P/B0.45
EPS (TTM)-2.08
EPS (Forward)
52W Range
0.91990% of range9.000
52W High9.000 USD
52W Low0.9199 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-94.18%
ROA-87.20%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-20.84M USD
CapEx (TTM)
FCF Margin
FCF Yield-42.21%
Net Debt-7.54M USD
Net Debt/EBITDA0.44
Balance Sheet
Debt/Equity
Current Ratio11.53
Quick Ratio7.92
Book Value/Sh2.233 USD
Cash/Share0.2220 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div DateNov 16, 2023
Pay DateDec 6, 2023
Splits
Last Split1:20
Split DateApr 17, 2023
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.34.03M
Float26.43M
Insiders11.96%
Institutions17.32%
Short Interest
Short Ratio0.2d
Short % Float0.26%
Short % Out.0.23%
Shares Short77.10K
Short (prev mo.)65.14K
Technical
SMA 501.149 (-17.8%)
SMA 2001.873 (-49.5%)
Beta0.08
S&P 52W Chg27.94%
Avg Vol (30d)385.12K
Avg Vol (10d)526.44K
Technical Indicators
RSI (14)36.2
MACD-0.0408
MACD Signal-0.0225
MACD Hist.-0.0183
BB Upper1.286 USD
BB Middle1.125 USD
BB Lower0.9648 USD
BB Width28.55%
ATR (14)0.0653 USD
Vol Ratio (20d)0.51x